Navigation Links
Albert Einstein College of Medicine hosts conference on Jewish genetic research
Date:6/11/2013

June 11, 2013 (BRONX, NY) Today, researchers at Albert Einstein College of Medicine of Yeshiva University convened a one-day conference on Jewish genetics designed to encourage collaboration and advance the field of research. Such research could help scientists identify causes and potential treatments for population-specific diseases as well as more common disorders afflicting the general population.

The genetic makeup of Ashkenazi Jews is relatively homogenous, which makes it easier to identify gene variations that cause disease. By bringing together scientists who investigate Jewish genetics with those at disease-specific research centers, the conference organizers hope to encourage new, productive research partnerships that could uncover the causes of debilitating conditions.

Twenty researchers from ten institutions are participating. From diabetes and arthritis to intellectual disabilities and Alzheimer's disease, a range of disorders are represented. Scientists studying Jewish genetics as well as those working with Latino/Hispanic, Amish and other racial and ethnic groups will also attend.

"We would like to see new research centers or other large-scale, multi-investigator studies established that can mine Jewish genomic data for clues to disease," said Harry Ostrer, M.D., one of the conference organizers and professor of pathology, of genetics, and of pediatrics at Einstein and director of genetic and genomic testing at Montefiore Medical Center, the University Hospital for Einstein.

"Several fruitful collaborations have already occurred in the field including the Jewish HapMap Project and The Ashkenazi Genome Consortium and we would like to expand that," noted Gil Atzmon, Ph.D., associate professor of medicine at Einstein.

In addition to Drs. Ostrer and Atzmon, other organizers of the conference are Nicole Schreiber-Argus, Ph.D., assistant professor of genetics at Einstein and Itsik Pe'er, Ph.D., at Columbia University.

The one-day event is titled "Genetic Research and Discovery in Jewish Populations: Toward Large-Scale Sustainable Efforts."


'/>"/>

Contact: Deirdre Branley
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related biology news :

1. University of Alberta researchers bake a better loaf of bread
2. University of Alberta research working towards treatment for aortic aneurysms in the abdomen
3. University of Alberta medical scientists first in the world to look at structure of vital molecule
4. Diets high in salt could deplete calcium in the body: UAlberta research
5. University of Albertas designer compounds inhibit prion infection
6. University of Alberta led research may have discovered how memories are encoded in our brains
7. U of Alberta researcher steps closer to understand autoimmune diseases
8. Einstein joins the New York Genome Center as 12th institutional founding member
9. Feinstein Institute collaborates with GSK, UPenn, MIT to research bodys electrical impulses
10. Einstein study reveals new approach for stopping herpes infections
11. Einstein receives $12 million grant to develop device for preventing HIV infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... , February 21, 2017 Der ... US-Dollar wachsen. Nach einem Gespräch mit mehr als 50 Vertretern ... Hindernisse zu überwinden gilt, um diese Prognose zu realisieren. ... ... die Mobilisierung der finanziellen Mittel für die Biobank, die ...
(Date:2/14/2017)... Feb. 14, 2017  Wake Forest Baptist Medical Center ... new chief executive officer (CEO). Freischlag joins the medical ... D. McConnell , M.D., who last year announced that ... Medical Center, after leading it since 2008.   ... of Wake Forest Baptist,s academic health system, which includes ...
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW ... therapies for solid tumor cancers, today announced that ... it announced last Friday, March 17, 2017. ... investors securities totaling 28,843,692 shares, comprised of 18,843,692 ... shares of Class C Warrants pre-funded at the ...
(Date:3/23/2017)... PARK, Calif., March 23, 2017  BioPharmX Corporation ... products for the dermatology market, today reported financial ... 31, 2017, and will provide an update on ... the year. "We are pleased to ... year for BioPharmX," said President Anja Krammer. "We ...
(Date:3/23/2017)... 2017 NetworkNewsWire Editorial Coverage  ... Cancer remains one ... on health care systems, in terms of costs and resources. ... does the development of innovative and efficient therapies that demonstrate ... many types of cancer treatments, a growing number of patients ...
(Date:3/23/2017)... In today,s pre-market research, Stock-Callers.com ... Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals ... and Regulus Therapeutics Inc. (NASDAQ: RGLS ). ... its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more ... ...
Breaking Biology Technology: